comparemela.com

ஐரோப்பிய கஞ்சா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cannabis grower sentenced after plants found at Ipswich home

RAMM Pharma to Acquire 100% of Leading Vertically

Company” or RAMM ) (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical and other cannabis-based products, is pleased to announce that the Company has entered into a definitive acquisition agreement with Canapar Corp. (“ Canapar”) and a wholly-owned subsidiary of the Company on May 11, 2021, that provides for the acquisition of all the common shares of Canapar (“ Canapar Shares”) that the Company does not currently own in exchange for an aggregate of approximately 21,904,095 common shares RAMM at a deemed value of $1.20 per Ramm Share (“ RAMM Shares”) for a total purchase price of approximately $26.2 million (the “ Transaction”). Based in Italy, Canapar is positioned to become one of Europe s largest vertically integrated cannabis companies. Canapar s state-of-the-art extraction facility is the largest in Europe and has been custom designed to produce active compounds to be used in high-quality pharmaceutical, wellness and cosmetic products from

Who are the medical cannabis patients in Europe? | Prohibition Partners

Who are the medical cannabis patients in Europe? | Prohibition Partners
prohibitionpartners.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prohibitionpartners.com Daily Mail and Mail on Sunday newspapers.

How this Vancouver company s plan to be a game-changer hinges on human trials of cannabis vapes

Nextleaf Solutions starts human trials of cannabis vapes The amended research licence allows the company to “rapidly formulate a wide variety of cannabis products and administer samples to volunteer research participants.” / Photo by Getty Images Nextleaf Solutions Ltd. is betting the information it receives from human trials of cannabis vapes will allow it to accelerate product development and drastically shorten design cycles for launching products. Following receipt of an amended Cannabis Research Licence from Health Canada, the Vancouver-based company announced last week that it kicked off what it characterizes as a ground-breaking human trial program of cannabis vapes. Data will be used to launch vape products into adult-use markets across Canada.

Key findings webinar on the European Cannabis Report: 6th Edition

Key findings webinar on the European Cannabis Report: 6th Edition
prohibitionpartners.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prohibitionpartners.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.